Publications

flavobacterium meningosepticum in israel.		1963	14077806
identification and typing of strains of flavobacterium meningosepticum and pasteurella hemolytica by the gel diffusion technic.		1965	14258473
[neonatal infections with flavobacterium meningosepticum. review of the problem apropos of 2 new congolese cases].		1965	14319169
neonatal infections with flavobacterium meningosepticum. report of two cases and a review.		1965	14348524
isolation of bacteria resembling flavobacterium meningosepticum from human material in britain.		1966	5931045
neonatal meningitis caused by flavobacterium meningosepticum type f.	two infants, one premature and one full-term, died from meningitis due to flav. meningosepticum type f. careful bacteriological studies are required to prevent possible confusion with other gram-negative bacilli which may cause meningitis in this age group.	1966	5904987
the importance of temperature for the growth of flavobacterium meningosepticum.		1966	6006195
a clinical analysis of 10 cases of postoperative infection with flavobacterium meningosepticum.		1967	6016783
an epidemiological study of hospital infection with flavobacterium meningosepticum.		1967	6016789
the sensitivity of flavobacterium meningosepticum to antibiotics at different temperatures. an in vitro study.		1967	5584517
an in vitro study of the antibiotic sensitivity of flavobacterium meningosepticum.		1967	5183810
flavobacterium meningosepticum isolated from outside hospital surroundings and during routine examination of patient specimens.		1969	5822968
meningitis caused by flavobacterium meningosepticum. the first epidemic outbreak of meningitis in the newborn in south america.		1970	5415050
flavobacterium meningosepticum. a bacteriological, epidemiological and clinical study.		1970	5454400
flavobacterium meningosepticum from neonatal meningitis.		1970	5311075
flavobacterium meningosepticum isolated from the genitals.		1971	5280414
meningitis in a new born due to flavobacterium meningosepticum.		1971	5161544
subacute bacterial endocarditis due to flavobacterium meningosepticum.		1972	4553132
deoxyribonucleic acid hybridization studies on flavobacterium meningosepticum.	seventeen flavobacteria, including 12 strains of flavobacterium meningosepticum, were investigated to determine their genetic relationships by deoxyribonucleic acid (dna)-dna hybridization and guanine plus cytosine content. the percentage of binding among the strains tested ranged from 6 to 87%. there was no correlation between the serotype and dna-duplex formation. the guanine plux cytosine content of the representative strains of the five serotypes ranged from 31 to 50%.	1973	4584592
[cerebrospinal meningitis due to flavobacterium meningosepticum in an infant].		1973	4731040
neonatal meningitis caused by flavobacterium meningosepticum.		1973	4773223
flavobacterium meningosepticum from cases of meningitis in botswana and england.	two strains of flavobacterium meningosepticum isolated from cases of meningitis are described. one was isolated in botswana from a man with an aplastic anaemia, the other in the uk from an infant who was probably infected in bangladesh. the severity of the infection, the characterization of the organism, and the possibility that infection may be found in the uk are discussed.	1973	4800468
[neonatal meningitis caused by flavobacterium meningosepticum: a case report].		1974	4215850
icu-acquired pneumonia due to flavobacterium meningosepticum.		1974	4406261
a comparison of strains of king's group iib of flavobacterium with flavobacterium meningosepticum.		1974	4599090
flavobacterium meningosepticum: a probable cause of meningitis in a cat.		1974	4450429
flavobacterium meningosepticum meningitis in a newborn infant. treatment with intraventricular erythromycin.		1974	4479533
hospital infections with pigmented water bacteria.	two types of cultures normally expected to be sterile, i.e., urine and blood, were chosen for review at a large university hospital. the bacteria isolated from urine cultures during 1966-70 and from blood cultures from 1966-73 are listed. two organisms, flavobacterium meningosepticum and pseudomonas cepacia, were selected for more detailed study and review. the antibiotic susceptibility patterns for these two organisms are presented.	1975	1236618
[a case of subacute bacterial endocarditis due to flavobacterium meningosepticum (author's transl)].		1975	1239477
occurrence of 2- and 3-hydroxy fatty acids in high concentrations in the extractable and bound lipids of flavobacterium meningosepticum and flavobacterium iib.	the major hydroxy fatty acids of cellular lipids in flavobacterium meningosepticum and flavobacterium sp. king's group uub were identified as 2-hydroxy 13-methyltetradecanoic, 3-hydroxy 13-methyltetradecanoic, 3-hydroxy palmitic, and 3-hydroxy 15-methylhexadecanoic acids using gas chromatography-mass spectrometry and gc-mass fragmentography. the concentration of these hydroxy fatty acids comprised up to 30-40% of the total extractable and 20-30% of the bound lipid fatty acids, respectively. from ...	1976	994759
rifamycin in neonatal flavobacteria meningitis.	three newborn infants with meningitis due to flavobacterium meningosepticum were treated with rifamycin administered parenterally and directly into the cerebral ventricles. antibiotic concentrations of blood and cerebrospinal fluid (csf) were monitored during treatment. there was rapid sterilization of the csf after this antibiotic. jaundice was the only toxicity noted. all 3 infants developed hydrocephalus and are shunt dependent. two of them are otherwise free of neurological complications and ...	1976	952554
[flavobacterium meningosepticum isolated from the oropharynx of a patient with acute myelogenous leukemia].		1976	828197
flavobacterium meningosepticum in the hospital environment.	ten strains of flavobacterium meningosepticum were isolated from routine clinical material during a period of two years. of a number of antibiotics tested, clindamycin was the only one to which they were fully sensitive. the organism was found in chlorhexidine gluconate (hibitane) solutions in use on the wards for the storage of thermometers and for routine disinfection.	1976	977783
[flavobacterium meningosepticum meningitis. clinical and bacteriological study of 2 cases treated in senegal].		1977	884786
[clinical and bacteriological study on flavobacterium meningosepticum (author's transl)].	the present study concerns in vitro observations on the susceptibility to antibiotics and chemotherapeutic agents of the strains of f. meningosepticum isolated from various clinical specimens at the clinical laboratory of juntendo university hospital and the assessment of their clinical significance of the patient, when they are isolated from clinical specimens. 1) fifty-two % of the strains was isolated from sputum, 20% from urine and 8% from pus and exudate. only 2 strains were obtained from b ...	1977	857060
[flavobacterium meningosepticum as the cause of meningitis in a premature infant].		1977	611436
two outbreaks of flavobacterium meningosepticum type e in a neonatal intensive care unit.	two separate outbreaks due to flavobacterium meningosepticum type e occurred in a neonatal intensive care unit in march-april and july 1975. the first outbreak involved all five infants in the unit. two infants developed meningitis, one had bacteremia, and two were colonized. during the second outbreak, five of seven infants were colonized but none developed disease. the upper respiratory tract was colonized first in most instances, and the organism persisted at this site for a mean of 17.3 days ...	1977	925147
[infection caused by flavobacterium meningosepticum, with special reference to purulent meningitis in newborn infants].		1977	405436
[flavobacterium meningosepticum (author's transl)].		1977	559147
flavobacterium meningosepticum as an opportunist.	flavobacterium meningosepticum was isolated from the cerebrospinal fluid of an adult immunodeficient female. in spite of prompt therapy the patient succumbed to the infection. the opportunistic role of the organism is discussed.	1978	641195
cellular fatty acids of flavobacterium meningosepticum and flavobacterium species group iib.	the cellular fatty acid profiles of flavobacterium meningosepticum and flavobacterium species group iib were markedly different from those of related bacteria. the profiles were characterized by the presence of 13-methyl-tetradecanoate and three uncommon acids: 2-hydroxy-13-methyl-tetradecanoate, 15-methyl-hexadecanoate, and 3-hydroxy-15-methyl-hexadecanoate.	1978	744804
flavobacterium meningosepticum meningitis: report of selected aspects.	two patients developed meningitis due to flavobacterium meningosepticum. because of resistance to most available antimicrobial agents, intravenous and intraventricular erythromycin was administered to one patient. subsequent development of resistance to erythromycin prompted the use of intravenous and intraventricular rifamycin, which eventually resulted in cure. diagnosis of f. meningosepticum meningitis in the second patient was delayed, and appropriate therapy was not administered until 4 day ...	1978	708021
[pyoventriculitis caused by flavobacterium meningosepticum; treatment with rifamycine].		1978	693224
[neonatal meningitis by "flavobacterium meningoseptium" (author's transl)].	we informed a case of neonatal meningitis caused by "flavobacterium meningosepticum", the first to be described in our country, taking into consideration its ethioepidemiology and therapy.	1978	566064
flavobacterium meningosepticum infections.		1979	451641
[flavobacterium meningosepticum infection in a 19-month-old girl].		1979	460114
[six new serotypes of "flavobacterium meningosepticum" (author's transl)].	six new serotypes (g to l) of flavobacterium meningosepticum are described herein. cross-reactions between the 12 serotypes, a to l (including the 6 serotypes a to f of owen and lapage, 1974) are described. sixty-six strains isolated in france (61 from strasbourg) belong to the following serotypes (with number of strains): a (1), f (4), g (51), h (1), i (1), j (6), k (1) and l (1). use of meningosepticum serotyping is recommended as an epidemiological tool.	1979	507635
in vitro activity of cefoperazone against nonfermenters and aeromonas hydrophila.	the in vitro activity of cefoperazone against 380 strains (33 species and unnamed groups) of nonferenters and 20 strains of aeromonas hydrophila was studied by a microdilution method of determining minimal inhibitory concentrations. for comparison, the activities of ampicillin, ticarcillin, and cefamandole were simultaneously studied. cefoperazone was the most active drug against pseudomonas sp., achromobacter xylosoxidans, flavobacterium meningosepticum. flavobacterium sp. (group iib), group iv ...	1980	6448581
[bacteremia due to flavobacterium meningosepticum. clinical and bacteriological aspects of patients (author's transl)].		1980	6782178
[2 cases of flavobacterium meningosepticum infection in a neonatology ward].		1980	7412550
meningitis of infants caused by flavobacterium meningosepticum: report of a patient and analysis of 63 infections.		1980	7420510
[the bacteriostatic and bactericidal effect of amniotic fluid (author's transl)].	the bacteriostatic and bactericidal effect of 100 samples of amniotic fluid (la) was studied against 5 bacterial species that are responsible for neonatal infections. these results show that there is a bacteriostatic activity in liquor. 52 specimens of liquor amnii (52%) were shown to be active against at least one of the 5 bacterial specimens studied. 32 samples of liquor (32%) were active against listeria monocytogenes, 21 (21%) against flavobacterium meningosepticum, 18 (18%) against escheric ...	1981	7024394
flavobacterium meningosepticum infection: an epidemiological study in a newborn nursery.	after an outbreak of flavobacterium meningitis in the newborn nursery of the university hospital, an investigation was carried out to determine the possible sources of this organisms in the nursery. various serotypes of the organism were recovered from a variety of sources such as wash basins, sinks, suction apparatus, and disinfectants in the nursery as well as the neighbouring wards. colonisation of the pharynx with this organism was demonstrated in several clinically healthy babies in the nur ...	1981	7240432
flavobacterium meningosepticum in the neonatal period.	we have described a term newborn infant who developed flavobacterium meningosepticum meningitis at 9 days of age. the case demonstrates the tenacity and changing antibiotic sensitivity of this organism. we used trimethoprim-sulfamethoxazole (bactrim) intravenously to obtain csf sterilization. on follow-up this child was neurologically intact.	1981	7244761
flavobacterium meningosepticum sepsis: disease due to bacteria with unusual antibiotic susceptibility.	the three cases we have presented implicate f meningosepticum as a significant pathogen causing disease in immunocompromised adult patients. since this organism is of low pathogenicity but may be found in the hospital environment, its identification as a pathogen raises the suspicion of a nosocomial source of infection, and a search for the source should be made. furthermore, with regard to the choice of antimicrobial therapy, it must be remembered that this organism is resistant to most antibio ...	1981	7244763
[perinatal infections with unusual pathogens. 3. flavobacterium meningosepticum].		1981	7279415
the laboratory diagnosis of opportunistic infections caused by uncommon bacteria in papua new guinea.	flavobacterium meningosepticum, chromobacterium violaceum and listeria monocytogenes are opportunistic pathogens of man and are occasional but important causes of infections in neonates, infants and adults in papua new guinea. mortality is high. flavobacterium meningosepticum should be suspected when a weak indole producing oxidase positive gram-negative bacillus producing a discrete yellow non-diffusing pigment at room temperature and showing a resistant antibiotic sensitivity pattern is isolat ...	1981	6951339
in vitro antimicrobial activity of ceftizoxime against glucose-nonfermentative gram-negative rods.	ceftizoxime, a new cephalosporin, was active against pseudomonas cepacia, flavobacterium meningosepticum, alcaligenes faecalis, and acinetobacter calcoaceticus and was more potent against pseudomonas aeruginosa and pseudomonas putida than was carbenicillin.	1981	6269480
flavobacterium meningosepticum ventriculitis: in vivo and in vitro results with the combinations rifampicin-erythromycin and mezlocillin-cefoxitin.	a case of flavobacterium meningosepticum ventriculitis is described in which the failure of therapy with a combination of rifampicin and erythromycin is attributed to inadequate antibiotic levels in cerebrospinal fluid. the successful eradication of the organism was achieved with the use of mezlocillin and cefoxitin given by the intravenous and intraventricular route. in vitro sensitivity tests of recently isolated strains of flavobacterium meningosepticum suggested that the combination mezlocil ...	1982	6217065
proline-specific dipeptidyl aminopeptidase from flavobacterium meningosepticum.	a proline-specific dipeptidyl aminopeptidase was highly purified from cell-free extract of flavobacterium meningosepticum by a series of column chromatographies on deae-sephadex a-50, sephadex g-150, hydroxyapatite, and a second gel filtration on sephadex g-150. the enzyme was most active at ph 7.4-7.8 for both gly-pro-beta-naphthylamide (gly-pro-2-nnap) and gly-pro-p-nitroanilide (gly-pro-pna) and was stable between ph 7 and 9.5. the enzyme was markedly inhibited by diisopropylphosphofluoridate ...	1982	6749829
the effects of temperature and ph on the growth of eight enteric and nine glucose non-fermenting species of gram-negative rods.	we studied the heat resistance and the range of growth temperature o gram-negative rods to find one of the bacterial factors governing their infectivity in exogenous and endogenous infections in predisposed patients. escherichia coli, klebsiella pneumoniae, serratia marcescens, pseudomonas aeruginosa, and acinetobacter calcoaceticus grew equally well at 25, 30, 37, and 42 c. among other sugar non-fermenting gram-negative rods, six species showed suppressed growth at either or both ends of the in ...	1982	7087800
successful therapy with rifampin--flavobacterium meningosepticum meningitis developing while on erythromycin therapy.		1982	7173459
a case of neonatal meningitis due to flavobacterium meningosepticum successfully treated with rifampin.		1982	7177894
endo-beta-n-acetylglucosaminidase f: endoglycosidase from flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins.	we have detected an endoglycosidase activity produced by flavobacterium meningosepticum. this enzyme, named endo f, cleaves glycans of both the high-mannose and the complex type linked through asparagine to the protein backbone. the data indicate that cleavage occurs via hydrolysis of the glycosidic bond of the n,n'-diacetylchitobiose core structure adjacent to asparagine, similar to that due to endo h and endo d. extreme variability was noted in the availability of this cleavage site among n-li ...	1982	6812050
[hospital infection caused by flavobacterium meningosepticum].		1982	7078943
meningitis caused by flavobacterium meningosepticum after transsphenoidal hypophysectomy with recovery.	adult meningitis caused by flavobacterium meningosepticum is rare. five cases have been reported in the literature. the case reported herein developed in a woman after a transsphenoidal hypophysectomy. the isolate was resistant to erythromycin. treatment with oral rifampicin combined with intravenous chloramphenicol and cefoperazone resulted in complete recovery.	1983	6623338
successful treatment of neonatal flavobacterium meningosepticum infection.	an 8-day-old, 2.48-kg, 35-week gestation infant developed neonatal sepsis and meningitis due to flavobacterium meningosepticum serotype f. treatment with a new antibiotic, azlocillin, in combination with chloramphenicol, led to complete recovery.	1983	6628455
rifampin therapy for brucellosis, flavobacterium meningitis, and cutaneous leishmaniasis.	rifampin has a broad antibacterial spectrum. at high concentrations it also is active in vitro against protozoa, i.e., different species of leishmania. rifampin has been used against bacterial and occasionally protozoal infections. addition of rifampin to a tetracycline regimen was found to reduce the number of relapses in patients with acute and chronic brucellosis. in a few cases of meningitis due to flavobacterium meningosepticum, which failed to respond to other drugs, patients were treated ...	1983	6635449
[isolation, identification and clinical significance of species of the flavobacterium genus].	strictly aerobic gram negative bacteria are found more and more often in human pathological specimens and in the environment. amongst these bacteria, flavobacterium poses problems of bacteriological diagnosis as their precise taxonomy is still recent. in this study, conducted on 321 strains of flavobacterium from various sources, but essentially from patients in the intensive care unit, the authors define the methods and features of identification and the clinical significance of the species of ...	1983	6354010
antimicrobial treatment of flavobacterium meningosepticum infection.	a six-month-old boy in hospital developed septicaemia and meningitis due to flavobacterium meningosepticum type a. although the organism was susceptible to amikacin, chloramphenicol and sulphonamides when tested by the disc diffusion method, therapy with these drugs was ineffective. intravenous therapy with cotrimoxazole gave complete recovery. various strains of flavobacteria including f. meningosepticum type b were isolated from the environment. antimicrobial susceptibilities of patients and e ...	1983	6197021
evidence showing that a proline-specific endopeptidase has an absolute requirement for a trans peptide bond immediately preceding the active bond.	the proline-specific endopeptidase (ec 3.4.21.26) from flavobacterium meningosepticum is specific for the cleavage of peptide bonds on the c-terminal side of prolyl residues. such bonds will normally exist in the all-trans configuration. however, the preceding peptide bond in the sequence (i.e., on the n-terminal side of the prolyl residue) will exist as a mixture of cis and trans forms in solution. in this study, the activity of the proline-specific endopeptidase toward the substrates n-cbz-gly ...	1983	6354257
[an in vitro study of susceptibility of flavobacterium meningosepticum to antibiotics].	the present study concern in vitro observation on the susceptibility to 20 antibacterial agents of the strains of flavobacterium meningosepticum from clinical specimens at juntendo university hospital during the 1 year period of 1981. the tests for susceptibility of the 144 strains to the drugs were all performed by the serial 2-fold agar plate dilution method on mueller hinton agar (difco), standardized by the japan society of chemotherapy using the microplanter apparatus with one loop of appro ...	1983	6551461
direct dilution sampling, quantitation, and microbial assessment of open-system ventilation circuits in intensive care units.	in a systematic approach, 37 duplicate samples of open system circuits (bennett ma-1 ventilators) of patients in medical and surgical intensive care units were processed by direct and serial (apha guidelines) dilutions. the paired difference test on 15 of the in-use circuitry solution samples indicated no difference between the direct and serial dilution methods (p less than 0.001). seventy-seven additional respiratory therapy circuitry samples from similar intensive care patients were analyzed ...	1983	6575015
meningitis in children of riyadh.	one hundred and forty cases of meningitis admitted to the children's hospital in riyadh from june 1980 to the end of may 1982 were included in a prospective study. sixty-seven percent were under 1 year of age and 90% were under 5 years old. one hundred and twenty-four (88.6%) had purulent csf, 12 (8.6%) had viral and four (2.9%) had tuberculous meningitis. e. coli was the commonest causative organism in the neonates. after that age s. pneumoniae was the predominant isolate. the implication of in ...	1984	6398834
collaborative evaluation of the abbott avantage system for identification of frequently isolated nonfermentative or oxidase-positive gram-negative bacilli.	the capability of the abbott avantage system to identify 10 species of commonly isolated glucose nonfermentative or oxidase-positive gram-negative bacilli in a 5-h test period was evaluated in a collaborative study. the avantage nonenteric data base uses 20 biochemical test reactions performed in an expanded abbott bacterial identification cartridge plus the results of a manual oxidase test. the species included in the avantage data base are acinetobacter anitratus, acinetobacter iwoffi, aeromon ...	1984	6392323
flavobacterium meningosepticum.	lavobacterium meningosepticum is an opportunistic pathogen of low virulence found in the hospital environment in water-containing equipment. of primary importance is its role in outbreaks of neonatal meningitis which tends to be severe with a high mortality rate and serious sequelae. changing all equipment concerned with humidifying or administering gases every 24 hours can help prevent these outbreaks in neonatal nurseries. treatment is difficult because of the resistance of f. meningosepticum ...	1984	6563023
biological activities of partially purified elastase produced by flavobacterium meningosepticum.	injection of viable cells of flavobacterium meningosepticum at doses of 10(6) colony-forming units/eye caused ophthalmia in rabbits' corneas. elastase, free of protease activity, was partially purified from broth cultures of f. meningosepticum atcc12535 and tms516. the optimum ph of the elastase activity was about 8.0. the activity was suppressed by ni, zn, co, edta, and o-phenanthroline, and accelerated by cu and fe. the minimum dose of the elastase causing ophthalmia in the eyes of rabbits was ...	1984	6335217
trimethoprim sulphamethoxazole in neonatal flavobacterium meningosepticum infection.	during an outbreak of flavobacterium meningosepticum septicaemia in a neonatal intensive care unit 9 infants were treated with intravenous trimethoprim sulphamethoxazole. bacteriological cure was achieved in 8 patients; one infant died of massive intraventricular haemorrhage on the first day of treatment. apart from prolonged persistence of pre-existing thrombocytopenia there was no evidence of side effects. trimethoprim sulphamethoxazole should be considered in the treatment of neonatal f menin ...	1984	6611137
[meningitis caused by flavobacterium meningosepticum in premature and newborn infants].		1984	6398420
demonstration of peptide:n-glycosidase f activity in endo-beta-n-acetylglucosaminidase f preparations.	endo-beta-n-acetylglucosaminidase f preparations from flavobacterium meningosepticum have been found to contain peptide:n-glycosidase activity. only the second activity, designated as peptide:n-glycosidase f, readily cleaves the beta-aspartylglycosylamine linkage of a fetuin triantennary complex glycopeptide, as shown by the isolation of the corresponding carbohydrate-free peptide containing aspartic acid and of an intact oligosaccharide with a di-n-acetylchitobiosyl moiety at the reducing end. ...	1984	6206060
successful treatment of prosthetic valve endocarditis due to flavobacterium meningosepticum.		1985	4049054
comparison of inhibitory effects of prolinal-containing peptide derivatives on prolyl endopeptidases from bovine brain and flavobacterium.	the inhibitory effects of proline-containing peptides and their derivatives on prolyl endopeptidases from flavobacterium meningosepticum and bovine brain were compared. replacement of the carboxyl terminal proline in n-blocked peptides with prolinal resulted in remarkable decreases in ki values for both prolyl endopeptidases. further reduction of the prolinal to prolinol led to a decrease in their inhibitory effects. z-pro-, z-val-, and suc-pro-prolinals were similarly inhibitory for both the en ...	1985	3908451
deglycosylation of asparagine-linked glycans by peptide:n-glycosidase f.	endo-beta-n-acetylglucosaminidase f (endo f) and peptide:n-glycosidase f (pngase f) were purified from cultures of flavobacterium meningosepticum by ammonium sulfate precipitation followed by gel filtration on tsk hw-55(s). this system separated the two enzymes and provided pngase f in a high state of purity, but the basis for the resolution appeared to be hydrophobic interaction and not molecular size. studies using purified endo f and pngase f with defined glycopeptides demonstrated that endo ...	1985	4063349
deglycosylation of alpha 1-proteinase inhibitor by endo-beta-n-acetylglucosaminidase f.	the glycosidase endo-beta-n-acetylglucosaminidase f (endo f) from flavobacterium meningosepticum was used for the deglycosylation of rat alpha 1-proteinase inhibitor (alpha 1 pi). alpha 1 pi containing three oligosaccharide side chains of the complex type was isolated from rat serum or from the medium of rat hepatocyte primary cultures. high-mannose-type alpha 1 pi or hybrid-type alpha 1 pi was isolated from the media of hepatocytes treated with 1-deoxymannojirimycin or swainsonine, respectively ...	1985	3935164
characteristic cellular fatty acid composition and an ornithine-containing lipid as a new type of hemagglutinin in bordetella pertussis.	the fatty acid composition of the total extractable cellular lipids of bordetella pertussis was very characteristic and was mostly hexadecenoic and hexadecanoic acids (90%) in a ratio of about 1:1. the fatty acid composition of bordetella parapertussis and bordetella bronchiseptica differed from that of b. pertussis. the two species were distinguished by the fatty acid composition of cell-bound lipids. the ornithine-containing lipid was characteristic of the genus bordetella and its main structu ...	1985	2872110
[neonatal meningitis caused by flavobacterium meningosepticum].		1986	3705038
oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than pseudomonas aeruginosa.	of 125 patients treated with ciprofloxacin at the columbia-presbyterian medical center, new york, 34 had infections due to bacteria other than pseudomonas aeruginosa. the mean age of the patients was 50 years (19-88 years) and most had significant underlying disease. there were nine lower respiratory infections, eight urinary tract infections, eight soft tissue infections, three osteomyelitis, and three intra-abdominal infections. the pathogens were: escherichia coli, 7 (mean mic 0.07 mg/l); ser ...	1986	3804906
[clinical evaluation of timentin in intensive care].	16 patients admitted to a micu were treated with timentin (ticarcillin + clavulanic acid) for bacterial infections: 11 cases of pulmonary infection, 3 cases of urinary tract infection, 2 septic shocks, 3 septicemias and 1 case of multifocal infection. the pathogens considered as a firmly established cause of infection were: 5 acinetobacter, 12 pseudomonas, 3 serratia, 4 klebsiella, 1 e. coli, 2 proteus, 1 providencia, 1 staphylococcus aureus, 1 staphylococcus epidermidis, 1 streptococcus d and 1 ...	1986	3534719
deglycosylation of gonadotropins with an endoglycosidase.	a commercially available endoglycosidase (n-glycanase, genzyme, boston, mass.) purified from flavobacterium meningosepticum with a specificity for cleaving asparagine-linked carbohydrate moieties in glycoproteins was tested on several pituitary and chorionic gonadotropins as substrates. all intact hormones tested were resistant to the action of the enzyme as were all beta subunits from the respective gonadotropins. all alpha subunits, however, were susceptible to the enzyme as evidenced by a dec ...	1986	3080756
menaquinone (vitamin k2)-6 production by mutants of flavobacterium meningosepticum.	flavobacterium meningosepticum ifo 12535, a menaquinone (mk) producer, was mutagenized to improve productivity. a mutant, which was resistant to 1-hydroxy-2-naphthoate (hna), was found to produce mk more abundantly: 34 mg/liter of culture broth and 5.5 mg/g of dry cells. the mutant was less sensitive to inhibition by hna on mk biosynthesis than the wild-type strain. mk was isolated from cells of the mutant and identified as mk-6 based on its physicochemical characteristics. mutants, which were g ...	1986	3761040
antibiotic resistance pattern of flavobacterium meningosepticum.		1986	3489618
transfer of glycerol by endo-beta-n-acetylglucosaminidase f to oligosaccharides during chitobiose core cleavage.	n-linked oligosaccharides, when hydrolyzed by glycerol-containing preparations of endo-beta-n-acetylglucosaminidase (endo) f from flavobacterium meningosepticum were found to have glycerol attached to their reducing ends. the absence of a reducing end was confirmed by high-field 1h nmr spectroscopy, and the incorporated glycerol was verified through mass spectrometry and collisionally activated decomposition fast atom bombardment/mass spectrometry/mass spectrometry techniques. periodate oxidatio ...	1986	3091595
flavobacterium meningosepticum bacteremia in an adult with acute leukemia. use of rifampin to clear persistent infection.	a case of flavobacterium meningosepticum bacteremia complicating the course of a patient with leukemia is described. the patient was treated successfully when rifampin was added to the antibiotic therapy. unusual organisms should be considered as agents of infection in immunocompromised hosts and susceptibility testing with drugs not commonly employed for gram-negative rods should be performed in complicated cases.	1986	3455909
sepsis from flavobacterium meningosepticum, an uncommon pathogen with unusual susceptibility patterns.	flavobacterium meningosepticum, because of its unusual susceptibility patterns and predilection for debilitated or immunocompromised hosts, can be a dangerous pathogen. identification of the organism and proper susceptibility studies, which are essential in designing antibiotic therapy, helped in the selection of a regimen that proved curative in this case.	1986	3704713
phenotypic and genetic relationships of so-called moraxella (pasteurella) anatipestifer to the flavobacterium/cytophaga group.	so-called moraxella (or pasteurella) anatipestifer and members of the flavobacterium/cytophaga group exhibit remarkable common features: lack of flagellation, low guanine + cytosine content of the chromosomal dna, production of menaquinones and branched-chain fatty acids, absence of carbohydrate fermentation, and similar patterns of hydrolytic enzymes. using the renaturation method of dna:dna hybridization two urease-negative european isolates and the urease-positive type strain (which was isola ...	1986	3739211
requirements of cleavage of high mannose oligosaccharides in glycoproteins by peptide n-glycosidase f.	peptide n-glycosidase from flavobacterium meningosepticum cleaves complex as well as neutral glycoproteins (plummer, t.h., jr., elder, j.h., alexander, s., phelan, a.w., and tarentino, a.l. (1984) j. biol. chem. 259, 10700-10704). examples of neutral glycoprotein substrates include ribonuclease b (one high mannose oligosaccharide chain) and yeast external invertase (nine chains/invertase subunit). the rate of deglycosylation by the glycosidase was greatly enhanced if the glycoprotein substrate w ...	1986	3941069
comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (ro 19-5247) and cefetamet (ro 15-8074).	the in vitro activities of two new oral cephalosporins, ceftetrame (ro 19-5247) and cefetamet (ro 15-8074), were tested against 990 clinical bacterial isolates in comparison with that of cephalexin. both compounds were more active than cephalexin against gram-negative bacteria, inhibiting most isolates of the family enterobacteriaceae at concentrations of less than or equal to 4 micrograms/ml, but were not active against acinetobacter species, most pseudomonas species, campylobacter jejuni, and ...	1987	3579264
neonatal meningitis by flavobacterium meningosepticum.		1987	3689534
peptide-n4-(n-acetyl-beta-glucosaminyl) asparagine amidase and endo-beta-n-acetylglucosaminidase from flavobacterium meningosepticum.		1987	3110550
classification and identification of flavobacterium species by carbon source utilization.	carbon substrates used as the sole source of carbon and energy were tested for the classification and identification of species of flavobacterium: flavobacterium meningosepticum, f. breve, f. odoratum, f. multivorum, f. thalpophilum, and flavobacterium sp. group iib. hierarchical classification and stepwise discriminant analysis revealed three f. meningosepticum, two f. breve, two f. odoratum, and two flavobacterium sp. group iib subgroups. glucose, histidine, asparagine, tryptophan, maltose, ci ...	1987	3611319